← Back to news

Markets

ImmunityBio’s (IBRX) ANKTIVA Gets Approved by UK’s Medicines and Healthcare Regulatory Agency

Y

Texas Instruments Stock Falls On Weak Earnings Outlook

Y

JPMorgan Chase: Homebuyers Now Have To Spend 45% More of Their Incomes on Mortgages — Is Homeownership Still Worth It?

Y

Sify Technologies (SIFY) Sees 14% YoY Revenue Growth in Q1 2026

Y

H.C. Wainwright Reiterates Buy Rating on Yatra Online (YTRA) Stock

Y

Easing Trade Tensions Boost Stocks but Chip Stocks Slide

Y

Dr. Reddy’s Laboratories (RDY) and Alvotech Enter Into a Collaboration and License Agreement

Y

Wipro (WIT) Reports Better-than-expected Quarterly Earnings, Highlights Reuters

Y

Roth Capital Lifts Price Objective on ReNew Energy Global (RNW) Stock

Y

Deutsche Bank Resumes Coverage of WNS (Holdings) (WNS) Stock

Y

MakeMyTrip (MMYT) Delivers Record Gross Bookings

Y

Infosys (INFY) Delivers $19,277 million in Revenues in FY 2025

Y

Oppenheimer Touts Marvell Technology (MRVL) as Top Data Center Play amid AI Infrastructure Ramp

Y

ICICI Bank Limited (NYSE:IBN) Beats Profit Forecasts, Says Reuters

Y

Alibaba Group Holding (BABA) Rated as a Buy at Benchmark amid Food Delivery Investments

Y

HDFC Bank (HDB) Reports Higher-than-expected Quarterly Profit

Y

Elastic NV’s (ESTC) Security Solution Affirms 100% Protection in Tests

Y

SentinelOne (S) Partners with Abstract to Boost AI-Powered Threat Detection

Y

Citizens JMP Affirms Market Perform Stance on Nice (NICE) Amid FAA Award

Y

Evercore Affirms ‘In Line’ Rating on Verint Systems (VRNT) amid Acquisition Reports

Y

Rezolve AI PLC (RZLV) To Support Stablecoin Transactions

Y

HIVE Digital Technologies Ltd. (HIVE) Rated as a Buy on Crypto and HPC Opportunities

Y

Jim Cramer is betting big on a financial stock that is seeking 'global domination'

F

Tesla Is Still Selling Glossy Future - GM Just Shipped 111% More EVs

Y

Strong Profits and Stable Outlook Boost Appeal of Innovative Solutions

Y

Vital Farms Expands Ethical Network, Balancing Growth with Market Calm

Y

AAON Secures Flexibility and Future Gains Despite Recent Market Jolt

Y

Harmony Biosciences Advances Pipeline While Navigating Analyst Caution

Y

FitLife Brands Holds on to Analyst Confidence Amid Mixed Sales and Online Strength

Y

PJT Partners Gains Momentum as Target Price Rise Despite Insider Selling

Y

Pinterest Rallies on User Surge and Global Ad Expansion Success

Y

Clearwater Analytics Strengthens Outlook Through Bloomberg Alliance and Analyst Support

Y

Argan Gains Analyst Praise While Executives Cash Out After Record Quarter

Y

Aave whales withdraw $1.7bn in Ethereum and trigger scramble to unwind looping trades

Y

Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition

Y

Heavy Insider Selling at ADMA Biologics Despite Earnings Strength

Y

6 Investing Moves That Benefit Millionaires, but Can Hurt the Middle Class

Y

Exelixis Gains Analyst Confidence as Cancer Studies Advances

Y

Corcept Advances Cancer Drug as Analysts Back Strong Growth Prospects

Y

Producers Midstream II to enhance Delaware Basin system

Y

Investor Bought Palantir At $28 In 2021 And Sold Too Soon. Now He's Banging His Head Over The Lifechanging Gains He Missed

Y

L3Harris CEO Notes "Inflection Point" In Defense Investment Cycle

Y

NextEra Energy Tops Profit Estimates as AI Data Center Demand Booms, Though Revenue Misses

Y

Jim Cramer on Eli Lilly: “It Needs Breakthroughs in New Areas”

Y

Jim Cramer on Cameco: “I Just Think That This is a Winner”

Y

Jim Cramer on Advanced Micro Devices: “It’s Going in the Right Direction”

Y

Jim Cramer Says “We Should be in ConocoPhillips”

Y

S&P 500 Sets Another New High. Why It’s Vulnerable to a Pullback.

Y

Jim Cramer Says “Make Centrus Your Speculative Position”

Y

Jim Cramer Says He Does Not Want Novo Nordisk Due to Tariffs

Y